Short Interest in Nanovibronix, Inc. (NASDAQ:FEED) Expands By 546.8%

Nanovibronix, Inc. (NASDAQ:FEED – Get Free Report) saw a large increase in short interest during the month of June. As of June 15th, there was short interest totaling 409,683 shares, an increase of 546.8% from the May 31st total of 63,342 shares. Based on an average daily trading volume, of 2,865,952 shares, the short-interest ratio is presently 0.1 days. Approximately 6.8% of the shares of the stock are short sold.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on FEED. Weiss Ratings reiterated a “sell (e+)” rating on shares of Nanovibronix in a research report on Friday, April 24th. Wall Street Zen upgraded Nanovibronix from a “strong sell” rating to a “sell” rating in a report on Tuesday, April 28th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Nanovibronix has an average rating of “Sell”.

Get Nanovibronix alerts:

Check Out Our Latest Stock Analysis on FEED

Insider Buying and Selling

In other Nanovibronix news, insider Christian Michael Glibert sold 210,000 shares of the business’s stock in a transaction that occurred on Monday, June 22nd. The stock was sold at an average price of $0.69, for a total transaction of $144,900.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.40% of the company’s stock.

Nanovibronix Price Performance

Shares of NASDAQ FEED traded up $0.01 during mid-day trading on Friday, reaching $0.58. 81,330 shares of the company’s stock were exchanged, compared to its average volume of 1,775,685. The stock’s 50-day moving average is $1.01. The firm has a market capitalization of $3.51 million, a price-to-earnings ratio of -0.07 and a beta of 1.51. Nanovibronix has a 52-week low of $0.55 and a 52-week high of $17.40.

Nanovibronix (NASDAQ:FEED – Get Free Report) last posted its earnings results on Monday, May 18th. The company reported ($6.88) EPS for the quarter. Nanovibronix had a negative net margin of 923.20% and a negative return on equity of 54.25%. The company had revenue of $0.65 million during the quarter.

About Nanovibronix

(Get Free Report)

Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non‑invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low‑intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound‑care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.

The company concentrates its commercial efforts on supplying hospitals, wound‑care clinics, long‑term care facilities and patients requiring home‑based therapies.

Featured Articles

• Five stocks we like better than Nanovibronix
• As Stablecoins Keep Growing, These 2 Stocks Benefit
• Apple Just Handed These 4 Memory Stocks Their Best News of the Year
• Costco’s Secret Growth Engine May Be Running Out of Gas
• Why Alphabet’s Pullback May Be an Opportunity in Disguise

Receive News & Ratings for Nanovibronix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanovibronix and related companies with MarketBeat.com's FREE daily email newsletter.